Services & Capabilities
Clinical Research Without the Academic Affiliation
Gain access to sponsored cardiovascular trials and registries, generating new revenue, deepening physician engagement, and positioning your practice at the leading edge of cardiovascular medicine.
Research Access Changes What Your Practice Can Offer
What’s Included
Research Infrastructure That's Already Built
Affiliated practices access a fully operational cardiovascular research platform without building a program from the ground up.
Sponsored Clinical Trials (Phase I–IV)
Access to sponsored cardiovascular drug trials across every phase: oral, injectable, and infusion-based therapies covering coronary artery disease, heart failure, arrhythmias, PAD, valvular conditions, and more. Trials are placed through Cardiovascular Research Solutions, LLC, CVAUSA's dedicated research entity.
Cardiovascular Device Trials
Full interventional capacity for device trials including pacemakers, stents, defibrillators, and wearable monitors with real-world data collection and centralized oversight built in. Practices with ASC or OBL capabilities are particularly well-positioned for device trial participation.
Centralized Research Infrastructure
Cardiovascular Research Solutions, LLC provides centralized regulatory oversight, standardized training, protocol implementation, and real-time monitoring across all participating sites so your team focuses on patient care, not research administration.
AI-Powered Patient Identification
AI-powered screening tools identify eligible trial participants from your existing patient panel, reducing manual chart review and cutting screening time significantly. 1.2M+ patients across our broader network is your greatest enrollment advantage.
Single IRB Coordination
One master IRB process across all participating sites reduces the regulatory burden on your practice and eliminates one of the most time-consuming bottlenecks in clinical trial participation. Site activation typically achieves a 30–60 day target.
Research Revenue Generation
Sponsored trials generate meaningful revenue for participating practices, paid per patient enrolled, per protocol visit, and per procedure completed. Research revenue is incremental to your clinical operations and requires no capital investment to access.
Our Benefits
What Research Access Changes for Your Practice
Open New Revenue Streams
Sponsored clinical trials generate revenue per patient enrolled, per protocol visit, and per procedure completed, incremental to your existing practice income and requiring no capital investment to access. For affiliated practices, research participation through Cardiovascular Research Solutions is one of the fastest paths to meaningful new revenue that doesn't compete with or disrupt clinical care.
Improve Recruitment and Retention
The cardiologists who built your practice are clinically excellent and many are motivated by more than patient volume. Access to sponsored Phase I–IV trials and device studies gives your physicians the intellectual engagement and professional recognition that independent practice has historically struggled to offer. Research participation is one of the most effective recruiting and retention tools available to an independent cardiovascular practice.
Access an Established Program
Building a clinical research program requires regulatory infrastructure, IRB coordination, protocol development, patient screening tools, and dedicated research staff. Cardiovascular Research Solutions provides all of it: centralized oversight, standardized protocols, AI-powered patient identification, and single IRB coordination across all participating sites. Your practice participates in a program that already works rather than spending years building one.
How It Works
From conversation to active trial participation in four steps.
Discovery Call
We learn about your practice's clinical capabilities, patient population, and research interests. No prior research experience is required. We support practices at every stage of research program development, from emerging to established.
Site Assessment
Our research team evaluates your practice's eligibility for active trials based on your clinical focus areas, patient panel, and facility capabilities. You receive a clear picture of which trials are available and what participation would look like for your team.
Site Activation and Training
Regulatory setup, IRB coordination, protocol training, and patient screening tools are configured for your site. CVRS handles the administrative infrastructure so your clinical team can focus on patient care. Site activation typically targets 30–60 days from agreement.
Active Participation & Ongoing Support
Your practice is live and enrolling. Real-time monitoring, standardized oversight, and ongoing support continues throughout the trial lifecycle, from enrollment through close-out. Research revenue begins generating as patients are enrolled and protocol visits are completed.
Is This Right For You?
FAQs About Our Cardiology Clinical Trials
If you have something specific you'd like to ask, we'd love to have a conversation.
No. Cardiovascular Research Solutions supports practices at every stage of research program development, from practices with no prior research experience to those with established programs looking to expand. Your site assessment will determine which trials are the right fit for your current capabilities, and CVRS provides the training and infrastructure to get you there.
The Heart Network's research platform covers the full spectrum of cardiovascular medicine: coronary artery disease, heart failure, arrhythmias and electrophysiology, peripheral artery and venous disease, valvular and structural heart conditions, and cardiometabolic conditions including hypertension, obesity, and diabetes. Both drug trials (Phase I–IV) and device trials are available, depending on your practice's clinical capabilities and facility infrastructure.
AI-powered screening tools identify eligible trial participants from your existing patient panel, significantly reducing the manual chart review burden on your staff. Your practice's existing patient relationships are one of the strongest enrollment advantages in the CVAUSA network, with community-based practices consistently outperforming academic sites on patient retention.
Your physicians serve as principal investigators or sub-investigators on participating trials and are involved in patient consent, protocol visits, and clinical decision-making. CVRS handles regulatory coordination, IRB management, data capture, monitoring, and administrative oversight, so the research burden on your clinical team is focused on patient care, not paperwork.
Site activation typically targets 30–60 days from agreement. Revenue begins generating as patients are enrolled and protocol visits are completed. The timeline to meaningful revenue depends on trial availability in your therapeutic areas and your patient panel's eligibility, both of which are assessed during the site evaluation phase.
Hear From Our Partners
Exceptional work and outstanding support. They delivered exactly what we needed on time and within budget. Highly recommended!
John Doe
CEO, Tech Corp
Exceptional work and outstanding support. They delivered exactly what we needed on time and within budget. Highly recommended!
John Doe
CEO, Tech Corp
Exceptional work and outstanding support. They delivered exactly what we needed on time and within budget. Highly recommended!
John Doe
CEO, Tech Corp
Exceptional work and outstanding support. They delivered exactly what we needed on time and within budget. Highly recommended!
John Doe
CEO, Tech Corp